J. Davies

发表

Vitamin D and melanoma

S. Field, J. Newton-Bishop, J. Davies, 2013, Dermato-endocrinology.

High nevus counts confer a favorable prognosis in melanoma patients

J. Malvehy, S. Puig, D. Glass, 2015, International journal of cancer.

Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148

Geoffrey S. Tobias, K. Nielsen, J. Malvehy, 2017, Nature Communications.

25‐Hydroxyvitamin D2/D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort

D. Bishop, J. Newton-Bishop, J. Davies, 2015, International journal of cancer.

Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study

D. Schadendorf, S. Puig, J. Barrett, 2012, Pigment cell & melanoma research.

The clinicopathological and gene expression patterns associated with ulceration of primary melanoma

H. Olsson, M. Lauss, K. Jirström, 2015, Pigment cell & melanoma research.

The determinants of serum vitamin D levels in participants in a melanoma case–control study living in a temperate climate

J. Barrett, D. Bishop, M. Harland, 2011, Cancer Causes & Control.

Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors.

J. Barrett, D. Bishop, H. Adami, 2016, JAMA dermatology.

Inherited variation in the PARP1 gene and survival from melanoma

Dirk Schadendorf, Susana Puig, Johan Hansson, 2014, International journal of cancer.

Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma.

G. Cook, D. Bishop, M. Harland, 2019, Cancer research.

Development and Validation of a Melanoma Risk Score Based on Pooled Data from 16 Case–Control Studies

Tim K. Lee, A. Ziegler, J. Barrett, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Plasma osteopontin concentrations in patients with cutaneous melanoma

D. Bishop, S. Field, M. Harland, 2013, Oncology reports.

Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity

D. Bishop, G. Ball, D. Adams, 2021, Pigment cell & melanoma research.

Development and Validation of a Melanoma Risk Score Based on Pooled Data from 16 Case–Control Studies

Tim K. Lee, A. Ziegler, J. Barrett, 2015, Cancer Epidemiology, Biomarkers & Prevention.

MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study

J. Barrett, G. Giles, J. Hopper, 2013, BMC Cancer.

Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies

K. Brown, J. Barrett, D. Bishop, 2018, The Journal of investigative dermatology.

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up

S. Barrans, C. Burton, D. Westhead, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Authors' reply to: High naevus counts confer a favourable prognosis in patients with melanoma

S. Puig, D. Glass, V. Bataille, 2015, International journal of cancer.

An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study

D. Schadendorf, S. Puig, J. Barrett, 2013, Pigment cell & melanoma research.

Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines

J. Barrett, D. Bishop, G. Giles, 2019, The British journal of dermatology.

The testing of the DAC algorithm for classifying Lymphoma Cell of Origin samples using HTG's targeted gene expression system

S. Barrans, C. Burton, M. Care, 2022, medRxiv.